The Peripheral Vascular Devices Market is set for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 6.9% from 2021 to 2028, reaching a market valuation of $12.02 billion by 2028. The driving forces behind this growth include the increasing prevalence of vascular diseases, the rise in secondary risk factors such as diabetes, obesity, unhealthy lifestyles, and aging, as well as the surging demand for minimally invasive treatment procedures within the peripheral vascular devices market.
Here are the top 10 companies operating in the Peripheral Vascular Devices Market:

Abbott Laboratories:

Abbott Laboratories is deeply involved in the research, development, manufacture, and sale of a comprehensive range of health technologies and products. Their offerings encompass diagnostics, medical devices, nutritional, and pharmaceutical products, tailored to meet customer needs.
The company operates through four distinct business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Their peripheral vascular devices are available through the Vascular subsegment under the Medical Devices business segment.
Abbott Laboratories maintains a global presence across several countries, including the U.S., China, Germany, Japan, India, Switzerland, and the Netherlands.

B. Braun Melsungen AG:

B. Braun Melsungen AG is a key player in the manufacturing, marketing, and distribution of products and services related to essential medical care, intensive care units, anesthesia and emergency care, extracorporeal blood treatment, and core surgical procedures worldwide.
The company offers a diverse portfolio, including infusion, nutrition, pain therapy, infusion pumps and systems, surgical instruments, suture materials, and more. Their products for the peripheral vascular devices market are provided through the B.Braun Aesculap business segment.
B. Braun Melsungen AG has a significant global footprint, spanning over 64 countries in Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa.

Becton, Dickinson and Company (BD):

Becton, Dickinson and Company (BD) is a prominent global medical technology company with a focus on medical research, genomics, infectious disease and cancer diagnosis, medication management, infection prevention, surgical and interventional procedures, and diabetes management.
BD primarily operates through three distinct business segments: BD Medical, BD Life Sciences, and BD Interventional. Their peripheral vascular devices are offered through the Peripheral Intervention unit under the

BD Interventional business segment.

BD has a broad global presence, manufacturing operations in numerous countries outside the U.S., and a wide-reaching distribution network.

Koninklijke Philips N.V.:

Koninklijke Philips N.V. is a health technology company renowned for its expertise in diagnostic imaging, image-guided therapy, patient monitoring, health informatics, consumer health, and home care.
The company delivers peripheral vascular devices through its Diagnosis & Treatment Business segment, operating in more than 100 countries worldwide with a substantial number of manufacturing sites.

Biotronik SE & Co. KG:

Biotronik SE & Co. KG is a privately held medical devices company based in Germany, specializing in the development, manufacturing, and sale of medical devices for the diagnosis and treatment of cardiovascular and endovascular diseases.

The company provides a wide array of products and services for cardiac rhythm management, vascular intervention, and electrophysiology. Their offerings for the peripheral vascular devices market are available through the peripheral vascular intervention portfolio.
Biotronik SE & Co. KG has a global presence in over 100 countries across Europe, North America, Asia-Pacific, Latin America, and the Middle East & Africa.

Boston Scientific Corporation:

Boston Scientific Corporation is actively engaged in the development, manufacturing, and marketing of an extensive range of medical devices, covering areas such as endoscopy, interventional cardiology, neuromodulation, peripheral interventions, rhythm management, urology, and pelvic health.
They operate through three distinct business segments: MedSurg, Rhythm and Neuro, and Cardiovascular, offering peripheral vascular devices through their Peripheral Interventions operating subsegment under the Cardiovascular business segment.

Cardinal Health, Inc.:

Cardinal Health, Inc. focuses on the development, manufacture, and supply of pharmaceuticals and medical products, catering to hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
Peripheral vascular devices are offered through their subsidiary, Cordis Corporation, within the Medical business segment.

Medtronic PLC:

Medtronic Public Limited Company is dedicated to the research, design, manufacturing, and sales of a wide range of device-based medical therapies and services.
Their peripheral vascular devices are provided through the Cardiac and Vascular Group business segment, which serves hospitals, clinics, third-party healthcare providers, distributors, and other institutions across more than 150 countries.

Cook Group:

Cook Group, headquartered in the U.S., offers a diverse portfolio encompassing medical devices, building materials, manufacturing, plastic, packaging, and containers.
Their subsidiary, Cook Medical, specializes in the development, manufacture, and sale of various medical devices, with a strong presence in 135 countries globally.

Edwards Lifesciences Corporation:

Edwards Lifesciences Corporation is dedicated to medical innovation, focusing on the development, manufacturing, and provision of products for the treatment of advanced cardiovascular disease.
Their peripheral vascular devices are available through the Critical Care segment, with a substantial presence in regions such as the U.S., Europe, and Japan.

Additionally, Meticulous Research forecasts a 6.9% growth rate for the Peripheral Vascular Devices Market between 2021 and 2028.